Factors Influencing the Development and Severity of Cognitive Decline in Patients with Chronic Heart Failure

Factors Influencing the Development and Severity of Cognitive Decline in Patients with Chronic Heart Failure

<i>Background and Objectives</i>: Considering the increasing prevalence of chronic heart failure (CHF) and cognitive decline (CD) observed in recent decades and the complex interrelation between these two pathologies often encountered in the same patient, in this study, we aimed to highl...

Full description

Saved in:

Bibliographic Details
Main Authors:	Marius Militaru, Daniel Florin Lighezan, Cristina Tudoran, Mariana Tudoran, Anda Gabriela Militaru
Format:	Article
Language:	English
Published:	MDPI AG 2024-11-01
Series:	Medicina
Subjects:	cognitive decline chronic heart failure dementia neuropsychological evaluation scales left-ventricular ejection fraction
Online Access:	https://www.mdpi.com/1648-9144/60/11/1859
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Microcirculation in heart failure: state of the art (literature review)
by: I. M. Davidovich, et al.
Published: (2025-02-01)

Adherence to treatment as an integral component of the management of patients with heart failure
by: V. N. Larina, et al.
Published: (2024-02-01)

Phenotypic clusters and biomarkers profile in patients with chronic heart failure with preserved and mildly reduced left ventricular ejection fraction
by: Natalia A. Dragomiretskaya, et al.
Published: (2024-12-01)

Assessment of prevalence and monitoring of outcomes in patients with heart failure in Russia
by: E. V. Shlyakhto, et al.
Published: (2020-12-01)

Cardiorenal relationships in patients with chronic heart failure with preserved ejection fraction
by: Yu. N. Panina, et al.
Published: (2023-11-01)

Pharmacoepidemiological analysis of routine management of heart failure patients in the Russian Federation. Part I
by: Yu. M. Lopatin, et al.
Published: (2021-05-01)

Current diagnostic algorithms for chronic heart failure with preserved left ventricular ejection fraction
by: Ya. Yu. Maistrovych, et al.
Published: (2023-03-01)

Left ventricular global function index: prognostic value in patients with heart failure aged 60 years and older
by: V. N. Larina, et al.
Published: (2020-11-01)

Characteristics, outcomes and the necessity of continued guideline-directed medical therapy in patients with heart failure with improved ejection fraction
by: Qin-Fen Chen, et al.
Published: (2025-12-01)

Modern echocardiographic criteria for heart failure with preserved ejection fraction: not only diastolic dysfunction
by: O. M. Drapkina, et al.
Published: (2020-04-01)

Prognostic value of atrial fibrillation in patients with heart failure and different left ventricular ejection fraction: results of the multicenter RIF-CHF register
by: I. V. Zhirov, et al.
Published: (2021-02-01)

Temporal left ventricular ejection fraction variations and outcomes in wide population of cardiovascular patients with and without heart failure
by: Radosław Szczerba, et al.
Published: (2025-03-01)

Survival after myocardial infarction according to left ventricular function and heart failure symptoms
by: Jarle Jortveit, et al.
Published: (2025-08-01)

Fibroblast Growth Factor‐23 and Heart Failure With Reduced Versus Preserved Ejection Fraction: MESA
by: Mohamed Faher Almahmoud, et al.
Published: (2018-09-01)

Baseline left ventricular ejection fraction predicts the magnitude of improvement in patients taking sacubitril/valsartan
by: José-Manuel Rubio-Campal, et al.
Published: (2025-06-01)

The Value of Biomarkers in the Diagnosis and Prognosis of Heart Failure in Older Age
by: V. N. Larina, et al.
Published: (2021-03-01)

Coronary Artery Disease Is A Stronger Predictor of All‐Cause Mortality Than Left Ventricular Ejection Fraction Among Patients With Newly Diagnosed Heart Failure: Insights From the WDHR
by: Roni Ranghoej Nielsen, et al.
Published: (2024-07-01)

Changes in left ventricular systolic function in patients with chronic heart failure with preserved ejection fraction and cardiorenal anemic syndrome.
by: V. A. Vasylenko
Published: (2015-09-01)

Changes in left ventricular systolic function in patients with chronic heart failure with preserved ejection fraction and cardiorenal anemic syndrome
by: Vasylenko V.A.
Published: (2015-09-01)

Efficacy of angiotensin receptor neprilysin inhibitor for maintenance hemodialysis patients with different types of left ventricular ejection fraction heart failure
by: Jin-cong Li, et al.
Published: (2024-12-01)

Medication adherence in patients with heart failure: a pilot observational study in outpatient practice
by: V. N. Larina, et al.
Published: (2024-12-01)

Effect of immunomodulation on cardiac remodelling and outcomes in heart failure: a quantitative synthesis of the literature
by: Navkaranbir S. Bajaj, et al.
Published: (2020-06-01)

Outcomes and Left Ventricular Ejection Fraction in Cardiac Magnetic Resonance: Challenging the “Higher Is Better”
by: Rungroj Krittayaphong, et al.
Published: (2025-04-01)

Electrocardiograph analysis for risk assessment of heart failure with preserved ejection fraction: A deep learning model
by: Zheng Gao, et al.
Published: (2025-02-01)

ARTERIAL STIFFNESS IN CHRONIC HEART FAILURE
by: O. M. Drapkina, et al.
Published: (2014-07-01)

An Observational Study on the Reversibility of Left Ventricular Diastolic Dysfunction, Impaired Left Ventricular Ejection Fraction and Abnormal Left Ventricular Mass with Levothyroxine Replacement in Primary Hypothyroid Patients of Indian Origin
by: Abhirup Chatterjee, et al.
Published: (2024-12-01)

Twenty-four-year-old patient with heart failure after myocarditis. Results of quadruple therapy: a case report
by: V. N. Larina, et al.
Published: (2023-04-01)

Risk Factors Influencing Right and Left Ventricular Variables Assessed with Gated Cadmium–Zinc–Telluride Equilibrium Radionuclide Angiocardiography in Oncology Patients
by: Olav Monsson, et al.
Published: (2025-05-01)

Predicting Cardiovascular Risk Factors for Acute Leukemia Patients by Assessing Subclinical Atherosclerosis and Left Ventricular Function Before Chemotherapy
by: Anda Gabriela Militaru, et al.
Published: (2025-04-01)

Automated ejection fraction and risk stratification in cardiomyopathy patients with diverse LV geometry using 2D echocardiography
by: Ziwei Zhu, et al.
Published: (2025-07-01)

The combination of left ventricular ejection fraction and end-diastolic diameter and outcomes in peritoneal dialysis patients: a multicenter retrospective study
by: Jiayin You, et al.
Published: (2025-12-01)

Clinical effect of three-dimensional left ventricular mechanical dyssynchrony and cardiac sympathetic denervation in systolic heart failure risk-stratified by left ventricular ejection fraction and QRS duration
by: Takahiro Doi, et al.
Published: (2025-06-01)

Comparison of Left Ventricular Global Longitudinal Strain and Left Ventricular Ejection Fraction in Acute Respiratory Failure Patients Requiring Invasive Mechanical Ventilation
by: Zubair Bashir, et al.
Published: (2024-10-01)

Pharmacoepidemiological analysis of routine management of heart failure patients in the Russian Federation. Part II
by: S. V. Nedogoda, et al.
Published: (2022-03-01)

Growth Differentiation Factor-15 (GDF-15) is a Biological Marker in Heart Failure
by: A. M. Alieva, et al.
Published: (2023-01-01)

Different Modes of Monitoring and Correction of Cardiac Function During Operations Under Extracorporeal Circulation
by: L. A. Krichevsky, et al.
Published: (2007-02-01)

Potential of primary drug prevention of cardiotoxicity in the context of anticancer therapy
by: Yu. A. Vasyuk, et al.
Published: (2023-01-01)

Left ventricular systolic longitudinal strain in mechanically ventilated patients in the intensive care unit: assessment of global and chamber reproducibility
by: Matías Pécora, et al.
Published: (2025-06-01)

Supramolecular complex sacubitril/valsartan - the first representative of a new class of drugs for the treatment of chronic heart failure
by: T. V. Ashcheulova, et al.
Published: (2019-12-01)

Diagnostic capabilities of instrumental methods for studying early cardiovascular adverse events in patients with lymphoproliferative disorders, quality and safety issues
by: G. R. Gimatdinova, et al.
Published: (2024-03-01)